Peptide Research Database

A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Reported in published Phase 3 research literature on adiposity and metabolic endpoints.

A dual GLP-1 and GIP receptor agonist studied in glycemic and adiposity research models.

A long-acting GLP-1 receptor agonist studied in glycemic control and weight-related research models.

A long-acting amylin analog studied in combination with semaglutide (CagriSema) in satiety and metabolic research models.

A GHRH analog studied in visceral adipose and GH-release research models.

A selective GHRP that stimulates GH release with minimal effect on cortisol or prolactin — among the cleanest GHRPs available.

A 29-amino acid peptide representing the active portion of GHRH, studied to stimulate natural GH production.

A modified GHRH analog without DAC, producing pulsatile GH release that more closely mimics natural GH secretion.

A modified GHRH analog with Drug Affinity Complex (DAC) that extends its half-life dramatically.

A popular GH peptide blend — CJC-1295 No DAC amplifies the GH pulse while Ipamorelin triggers it cleanly without cortisol or prolactin elevation.

A pentadecapeptide derived from a protective gastric protein. One of the most studied healing peptides with a wide range of regenerative properties.

A synthetic fragment of Thymosin Beta-4 studied for cellular migration, tissue repair, and inflammation modulation.

A synergistic combination of BPC-157 and TB-500 studied for comprehensive tissue repair through complementary mechanisms.

A naturally occurring copper-binding peptide studied for wound healing, cellular aging, and tissue regeneration.

A tripeptide derived from the C-terminal of alpha-MSH studied for anti-inflammatory effects, particularly in gut models.

A research blend combining multiple healing peptides (typically GHK-Cu, BPC-157, TB-500, KPV) studied for synergistic tissue repair effects.

A mitochondrial-derived peptide studied for metabolic homeostasis, insulin sensitivity, and cellular energetics.

A coenzyme found in all living cells studied for energy metabolism, DNA repair, and cellular aging research.

A synthetic analog of ACTH(4-7) developed in Russia studied for nootropic and neuroprotective effects.

A synthetic analog of tuftsin with nootropic, anxiolytic, and immunomodulatory properties in research models.

A synthetic analog of alpha-MSH studied for stimulating melanogenesis (melanin production) in research models.

A melanocortin receptor agonist studied for central nervous system signaling in research models.

A neuropeptide that stimulates GnRH release, driving LH and FSH — studied in reproductive hormone regulation.

A glycoprotein hormone studied in reproductive and endocrine research models.

A lipotropic blend studied for fat metabolism research, typically combining methionine, inositol, choline, and B-vitamins.

A neuropeptide studied for slow-wave sleep promotion, stress reduction, and disrupted-sleep models.

A tetrapeptide derived from the pineal gland studied for telomerase activation and cellular aging.

A synthetic analog of alpha-MSH studied for stimulating melanogenesis (melanin production) without UV exposure. More selective and longer-acting than Melanotan-2.

An ERR (estrogen-related receptor) agonist that activates pathways normally triggered by endurance exercise — earning the nickname 'exercise in a bottle' in research literature.

A mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane, preserving cristae structure and improving ATP production. Studied in aging, heart failure, and metabolic disease.

A peptide complex derived from the thymus gland studied for restoring immune function, T-cell maturation, and broad cellular aging / longevity effects — extensively researched in Russian gerontology literature.

A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that re-activates fat-cell metabolism. Preclinical studies show reduced adiposity and improved metabolic markers without appetite suppression.